Keywords: calls, halt, off-label, use, genotropin, pointing, mortality

P&U Calls Halt To Off-Label Use Of Genotropin

Article | 04 December 1997

Print This

Pointing to the mortality rate in two European Phase III trials of itshuman growth hormone product Genotropin (somatropin) for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in